Fungal infections of the mucous membrane

Dermatologic Therapy

Volumn 23, Issue 3, 2010, Pages 243-250

  Marques, Silvio Alencar ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Fungal infections; Histoplasmosis; Mucormycosis; Mucous membrane; Paracoccidioidomycosis; Treatment

Indexed keywords

AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; COTRIMOXAZOLE; DEFERASIROX; FLUCONAZOLE; HYDROCORTISONE; ITRACONAZOLE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; ORAL ANTIDIABETIC AGENT; POSACONAZOLE; PROTEINASE INHIBITOR; SILDENAFIL; SULFAMETHOXAZOLE; TUBERCULOSTATIC AGENT; VORICONAZOLE; WARFARIN; ANTIFUNGAL AGENT;

CHILL; CLINICAL FEATURE; CYTOLOGY; DEBRIDEMENT; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG POTENTIATION; DRUG TOLERABILITY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HISTOPATHOLOGY; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPOMAGNESEMIA; KIDNEY CLEARANCE; KIDNEY TUBULE ACIDOSIS; MALAISE; MUCORMYCOSIS; MYCOSIS; NEPHROTOXICITY; NONHUMAN; ORAL MUCOSAL DISEASE; PARACOCCIDIOIDES BRASILIENSIS; PATHOGENESIS; RECOMMENDED DRUG DOSE; REVIEW; SIDE EFFECT; SKIN DISEASE; SOUTH AMERICAN BLASTOMYCOSIS; STEVENS JOHNSON SYNDROME; TACHYCARDIA; TACHYPNEA; TOXIC EPIDERMAL NECROLYSIS; ADULT; CHILD; DRUG ADMINISTRATION; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; MICROBIOLOGY; MOUTH DISEASES; MOUTH MUCOSA; PARACOCCIDIOIDOMYCOSIS;

ADULT; ANTIFUNGAL AGENTS; CHILD; DRUG ADMINISTRATION SCHEDULE; HISTOPLASMOSIS; HUMANS; IMMUNOCOMPROMISED HOST; MOUTH DISEASES; MOUTH MUCOSA; MUCORMYCOSIS; PARACOCCIDIOIDOMYCOSIS;

EID: 77952712578     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2010.01321.x     Document Type: Review

References (30)

1. Restrepo A, Benard G, de Castro CC, Agudelo CA, Tobón AM. Pulmonary paracoccidioidomycosis. Semin Respir Crit Care Med 2008 : 29 : 182 197.
2. McEwen JG, Bedoya V, Patino MM, Salazar ME, Restrepo A. Experimental murine paracoccidioidomycosis induced by the inhalation of conidia. J Med Vet Mycol 1987 : 25 : 165 175.
3. Padilha-Gonçalves A. Paracoccidioidomicose: classificaç ão. An Bras Dermatol 1985 : 60 : 271 280.
4. Del Negro G, Lacaz CS, Zamith VA, Siqueira AM. General Clinical Aspects: Polar Forms of Paracoccydioidomycosis, the Disease in Childhood. In : Franco MLC, Restrepo-Moreno A, Del Negro G, eds. Paracoccidioidomycosis, Vol. 1.
5. Franco M, Montenegro MR, Mendes RP, Marques SA, Dillon N, Mota NGS. Paracoccidioidomycosis: a recently proposed classification of its clinical forms. Rev Soc Bras Med Trop 1987 : 20 : 129 132.
6. Mendes RP. The Gamut of Clinical Manifestations. In : Franco MLC, Restrepo-Moreno A, Del Negro G, eds. Paracoccidioidomycosis, Vol. 1.
7. Marques SA, Cortez DB, Lastória JC, Camargo RMP, Marques MEA. Paracoccidioidomycosis: frequency, morphology and pathogenesis of tegumentary lesions. An Bras Dermatol 2007 : 82 : 411 417.
8. Shikanai-Yasuda MA, Conceição YM, Kono A, Rivitti E, Campos AF, Campos SV. Neoplasia and paracoccidioidomycosis. Mycopathologia 2008 : 165 : 303 312.
9. Montenegro MR, Franco M. Pathology. In : Franco MLC, Restrepo-Moreno A, Del Negro G, eds. Paracoccidioidomycosis.
10. Shikanai-Yasuda MA, Queiroz-Telles F, Mendes RP, Colombo AL, Moretti ML. Consenso em paracoccidioidomicose. Rev Soc Bras Med Trop 2006 : 39 : 297 310.
11. Queiroz-Telles F, Goldani LZ, Schlamm HT, Goodrich JM, Espinel-Ingroff A, Shikanai-Yasuda MA. An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of paracoccidioidomycosis. Clin Infect Dis 2007 : 45 : 1462 1469.
12. Mendes RP, Negroni R, Arechavala A. Treatment and Control of Cure. In : Franco MLC, Restrepo-Moreno A, Del Negro G, eds. Paracoccidioidomycosis.
13. Mahon SM. Taking the terror out of amphotericin B. Am J Nurs 1988 : 88 : 960 964.
14. Dietze R, Fowler VG Jr., Steiner TS, Pecanha PM, Corey GR. Failure of amphotericin B colloidal dispersion in the treatment of paracoccidioidomycosis. Am J Trop Med Hyg 1999 : 60 : 837 839. (Pubitemid 29233090)
15. Yasuda MA. Pharmacological management of paracoccidioidomycosis. Expert Opin Pharmacother 2005 : 6 : 385 397.
16. Sadick NS. Systemic Antibacterial Agents. In : Wolverton SE, ed. Comprehensive dermatologic drug therapy, 1st ed.
17. Gupta AK. Systemic Antifungal Agents. In : Wolverton SE, ed. Comprehensive dermatologic drug therapy, 1st ed.
18. Daher EF, Silva GB Jr., Barros FA, et al. Clinical and laboratory features of disseminated histoplasmosis in HIV patients from Brazil. Trop Med Int Health 2007 : 12 : 1108 1115.
19. Tobon AM, Agudelo CA, Rosero DS, et al. Disseminated histoplasmosis: a comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals. Am J Trop Med Hyg 2005 : 73 : 576 582.
20. Vail GM, Young RS, Wheat LJ, Filo RS, Cornetta K, Goldman M. Incidence of histoplasmosis folowing allogenic bone marrow transplant or solid organ transplant in a hyperendemic area. Transpl Infect Dis 2002 : 4 : 148 151.
21. Karimi K, Wheat LJ, Connoly P, et al. Differences in histoplasmosis in patients with aquired immunodeficiency syndrome in the United States and Brazil. J Infect Dis 2002 : 186 : 1655 1660.
22. Hernandez SL, López DBS, Sambuelli RH, et al. Oral histoplasmosis associated with HIV infection: a comparative study. J Oral Pathol Med 2004 : 33 : 445 450.
23. Nico MM, Higashino HR, Yeh Li H, Carvalho NB, Lourenço SV. Exuberant mucocutaneous lesions of disseminated histoplasmosis in a human immunodeficiency virus (HIV) positive patient. Int J Dermatol 2009 : 48 : 157 159.
24. Wheat J, Freifeld AG, Kleiman MB, et al. Practice guidelines for the management of patients with histoplasmosis. Clin Infect Dis 2007 : 45 : 807 825.
25. Restrepo A, Tobon A, Clark B, et al. Salvage treatment of histoplasmosis with posaconazole. J Infect 2007 : 54 : 319 327.
26. Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis 2009 : 48 : 1743 1751.
27. Bonifaz A, Macias B, Paredes-Farreira F, Arias P, Ponce RM, Araiza J. Palatal zygomycosis: experience of 21 cases. Oral Dis 2008 : 14 : 569 574.
28. Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 2000 : 30 : 851 856.
29. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002 : 34 : 909 917. (Pubitemid 34229758)
30. Nick H, Wong A, Acklin P, et al. ICL670A: preclinical profile. Adv Exp Med Biol 2002 : 509 : 185 203.